Incyte Corp. diskutieren
Incyte Corp.
WKN: 896133 / Symbol: INCY / Name: Incyte / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
89,44 €
2,68 %
Incyte Corporation (NASDAQ: INCY) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $89.00 price target on the stock, up previously from $67.00.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its price target raised by analysts at Bank of America Corporation from $90.00 to $104.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its price target raised by analysts at Stifel Nicolaus from $110.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $125.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its price target raised by analysts at Piper Sandler from $82.00 to $102.00. They now have an "overweight" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) was given a new $121.00 price target on by analysts at Mizuho. They now have an "outperform" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $121.00 price target on the stock, up previously from $90.00.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for INCY provided by MarketBeat
Incyte (NASDAQ:INCY) had its price target raised by analysts at TD Cowen from $101.00 to $128.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (INCY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $135.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (INCY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $135.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (INCY) had its price target raised by Stifel Nicolaus from $120.00 to $123.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (INCY) had its "buy" rating reaffirmed by HC Wainwright. They now have a $135.00 price target on the stock.
Ratings data for INCY provided by MarketBeat
Incyte (INCY) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for INCY provided by MarketBeat
Incyte (INCY) had its price target raised by HC Wainwright from $135.00 to $140.00. They now have a "buy" rating on the stock.
Ratings data for INCY provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Société Générale S.A. ADR diskutieren